APA (7th ed.) Citation

Stockem, C., van Rhijn, B., Boellaard, T., van Montfoort, M., Balduzzi, S., Boormans, J., . . . van der Heijden, M. (2022). 1780TiP A phase II clinical study to assess efficacy of induction ipilimumab/nivolumab to spare the bladder in urothelial bladder cancer (INDI-BLADE). Annals of Oncology, 33, S1351. https://doi.org/10.1016/j.annonc.2022.07.1939

Chicago Style (17th ed.) Citation

Stockem, C.F, et al. "1780TiP A Phase II Clinical Study to Assess Efficacy of Induction Ipilimumab/nivolumab to Spare the Bladder in Urothelial Bladder Cancer (INDI-BLADE)." Annals of Oncology 33 (2022): S1351. https://doi.org/10.1016/j.annonc.2022.07.1939.

MLA (9th ed.) Citation

Stockem, C.F, et al. "1780TiP A Phase II Clinical Study to Assess Efficacy of Induction Ipilimumab/nivolumab to Spare the Bladder in Urothelial Bladder Cancer (INDI-BLADE)." Annals of Oncology, vol. 33, 2022, p. S1351, https://doi.org/10.1016/j.annonc.2022.07.1939.